972P Efficacy and safety of lenvatinib vs sorafenib in hepatocellular carcinoma: A multi-center real-world study from the LINK Research Network

Jung Yong Hong(Samsung Medical Center), Ji Hoon Kim(Korea University), B-Y. Ryoo(Ulsan College), Sung Hee Lim(Samsung Medical Center), Dong‐Han Lee(IQVIA (United Kingdom)), Dong Hyun Sinn(Samsung (South Korea)), Kihyun Kım(State University of New York), Dong Wook Kim(Yonsei University), Do Young ‍Kim(Yonsei University), Ki‐Hyun Kim(Hanyang University), Mi Jung Lee(Yonsei University Health System), Minjung Kang(Samsung Medical Center), Eun-Ju Choi(IQVIA (United Kingdom)), W.C. Cha(Samsung Medical Center), K-P. Kim(Ulsan College), Woo Kyoung Jeong(Sungkyunkwan University), W-M. Choi(Ulsan College), C. Jung(IQVIA (United Kingdom))
Annals of Oncology
September 1, 2024
Cited by 0


Related Papers